HCAT — Health Catalyst, Inc.
—
Nasdaq ·
Information Technology ·
IT Services ·
CIK 1636422 ·
Last close
$1.37
Market Cap
$104.33M
52W High
$3.03
52W Low
$0.95
ADV30
399,454
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 56,283,000 | 24,041,000 | -15,752,000 | 40,496,000 | 237,419,000 | 53,746,000 | 91,833,000 |
| Jun 2026 | 70,487,000 | 34,860,000 | -9,433,000 | -40,537,000 | 358,604,000 | 60,589,000 | 257,777,000 |
| Mar 2026 | 70,756,000 | 35,463,000 | -7,163,000 | -111,026,000 | 412,202,000 | 59,864,000 | 274,057,000 |
| Dec 2025 | 74,679,000 | 39,383,000 | 3,261,000 | -91,025,000 | 502,643,000 | 50,814,000 | 256,863,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$28,234,000
Investing CF
$-16,848,000
Financing CF
$-1,425,000
CapEx
$-21,683,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-3.68
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,516,209,000
Inventory
—
Receivables
$41,901,000
ST Investments
$42,850,000
EBIT TTM
$-243,129,000
Pretax Income TTM
$-263,668,000
Interest Exp TTM
$20,539,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$272,204,992
EBITDA
$-119,000
Free Cash Flow
$29,866,376
Enterprise Value
$47,948,980
Total Cash
$78,991,000
Total Debt
$15,753,000
Shares Out
76,155,467
Trailing EPS
$-2.80
Book Value
$1.91
ROE
-84.6%
ROA
-5.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 311,136,000 | -42,744,000 | -177,974,000 | 502,643,000 | 256,863,000 | 245,780,000 | 731,000 |
| Dec 2024 | 306,584,000 | -57,613,000 | -69,502,000 | 858,929,000 | 493,722,000 | 365,207,000 | 14,559,000 |
| Dec 2023 | 295,938,000 | -99,999,000 | -118,147,000 | 701,814,000 | 334,895,000 | 366,919,000 | -33,080,000 |
| Dec 2022 | 276,236,000 | -140,005,000 | -137,403,000 | 752,286,000 | 327,276,000 | 425,010,000 | -35,270,000 |
TTM Snapshot
Revenues TTM
$292,245,000
NetIncome TTM
$-264,817,000
OpCashFlow TTM
—
Assets (Latest)
$358,604,000
Forward EPS
$0.01
Max Pain — expiry 2026-12-18
max pain strike: $2.50 · spot: $1.29 · call oi: 21,534 · put oi: 15,955Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FVN | Future Vision II Acquisition Corp. | $98.98M | $13.12 | — |
| GLOO | Gloo Holdings, Inc. | $111.40M | $2.77 | — |
| DOYU | DouYu International Holdings Ltd | $111.66M | $3.70 | — |
| TRVG | trivago N.V. | $97.10M | $4.21 | — |
| RZAI | ROZE AI INC. | $95.15M | $1.71 | — |
News headlines (Yahoo Finance, 1h cache)
HCAT Q3 2026 deep dive: client retention and cost alignment take center stage
2026-11-09 03:57 · Yahoo
Health Catalyst, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Health Catalyst Inc (HCAT) (Q3 2026) Earnings Call Highlights: Revenue and EBITDA Beat Guidance ...
2026-11-06 13:14 · Yahoo
Health Catalyst (HCAT) Q3 2026 Earnings Call Transcript
2026-11-06 08:47 · Yahoo
What Health Catalyst (HCAT) Said on Its Q3 Earnings Call
2026-11-06 06:14 · Yahoo
Health Catalyst (HCAT) Reports Q3 Loss, Beats Revenue Estimates
2026-11-06 00:00 · Yahoo
Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings
2026-11-05 23:00 · Yahoo
Health Catalyst (NASDAQ:HCAT) exceeds Q3 2026 expectations
2026-11-05 22:51 · Yahoo
Health Catalyst: Q3 Earnings Snapshot
2026-11-05 21:53 · Yahoo
Health Catalyst Reports Third Quarter 2026 Results
2026-11-05 21:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.